Anavex Life Sciences Corp.
AVXL· Nasdaq
AVXLAnavex Life Sciences Corp.
Filed May 10, 2018 · 10-Q · 40 days after period end · 0001615774-18-003574
| Metric | Q2 2018 | Q2 2017 | Q2 2016 | Q2 2015 |
|---|---|---|---|---|
| Net Income | -$4.75M | -$1.55M | -$2.03M | -$1.72M |
| EPS Diluted | -$0.11 | -$0.04 | -$0.06 | -$0.12 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Anavex Life Sciences Corp. · CIK 1314052 · Engraved from SEC EDGAR
ended Mar 31, 2018 · filed May 10, 2018 · 40 d after period end
